Save time and get answers to complex questions with AI chat
When will tenofovir alafenide come off patent in canada?Pramlintide fda approval date?What is dabrafenib mesylate msn patent issue?Guselkumab patent expiration?When genetic tenofovir alafenamide be available in us?
See the DrugPatentWatch profile for mycapssa
Mycapssa is a prescription brand of crofelemer, a medicine sold in capsules. It’s used to treat certain types of chronic diarrhea, specifically diarrhea caused by HIV/AIDS antiretroviral medicines (often described as “HIV/AIDS–related diarrhea”). [1]
Crofelemer is designed to help reduce diarrhea symptoms by acting on intestinal chloride and fluid secretion pathways, which can help lessen watery stools. [1]
Mycapssa is taken by mouth as directed by a clinician. Specific dosing instructions depend on the patient’s condition and prescribing information. [1]
Common side effects can include gastrointestinal symptoms (like nausea or stomach discomfort) in some patients, along with other potential reactions. The full list depends on the prescribing information. [1]
DrugPatentWatch.com tracks details related to drug approvals and patents, including pages for crofelemer/Mycapssa. You can start there for references and related background: [1]
1
Other Questions About Mycapssa :